Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses
2015 · Molecular Therapy · 184 citations
https://doi.org/10.1038/mt.2015.115
T
Thomas Wirth
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
298
Papers
8.2K
Citations
48
h-index
122
i10-index
Thomas Wirth is an academic researcher from Medizinische Hochschule Hannover. The author has contributed to research in topics: Immunotherapy and Immune Responses & Cancer Immunotherapy and Biomarkers & Hip disorders and treatments. The author has an h-index of 48, co-authored 254 publications.
ORCID: 0000-0001-8335-5330Papers by this author
worksAdministration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells
2016 · Gastroenterology · 90 citations
https://doi.org/10.1053/j.gastro.2016.05.004
Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy
2019 · Nature Communications · 64 citations
https://doi.org/10.1038/s41467-019-11137-5
Oct2 Transactivation from a Remote Enhancer Position Requires a B-Cell-Restricted Activity
1992 · Molecular and Cellular Biology · 60 citations
https://doi.org/10.1128/mcb.12.7.3107-3116.1992
The orthopaedic management of long bone deformities in genetically and acquired generalized bone weakening conditions
2019 · Journal of Children s Orthopaedics · 26 citations
https://doi.org/10.1302/1863-2548.13.180184
Sequential STING and CD40 agonism drives massive expansion of tumor-specific T cells in liposomal peptide vaccines
2025 · Cellular and Molecular Immunology · 7 citations
https://doi.org/10.1038/s41423-024-01249-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat